Anise (Aniseed) and menopause symptoms

What 2 graded rows on anise (aniseed) agree on for menopause symptoms, and where they differ. Counted side by side, never averaged.

Consensus finder Rows from the Anise (Aniseed) page, reviewed Oct 21, 2026 How it decides

What the rows agree on

Each block and row is one graded row from the Anise (Aniseed) page, with its PubMed record.

Supplement

Anise (Aniseed) Choose another

2 rows · 132 people

They agree: both rows found an improvement.

No difference

Improved

Each block is one evidence row, sized by how many people it enrolled, with its grade inside.

From the rows

The best-graded row, grade D, is a randomized trial of 72 people (2012) and found an improvement.

The rows run from 60 to 72 people, published from 2012 to 2026: 2 single studies.

2 improved

Grade DMenopausal hot flash frequency and severity · Improved
RCT · n 72 · 2012 · Postmenopausal women with hot flashes attending health centres in Qazvin, Iran
330 mg three times daily (990 mg/day) · 4 weeks, plus 4 weeks follow-up
On anise, the hot flash frequency measure fell from 4.21 to 1.06 and severity from 56.21 to 14.44 by week 4, and stayed lower during follow-up; neither changed on placebo.
Row on the Anise (Aniseed) page · PubMed 24250540 (opens PubMed)
Grade DDepression, anxiety and stress scores (DASS-21) and menopausal symptom index in menopausal women · Improved
RCT · n 60 · 2026 · Menopausal women with psychological symptoms (India)
4 g a day in two divided doses · 8 weeks
DASS-21 scores fell more on anise than placebo at 8 weeks (p < 0.0001), and the Modified Kupperman Index and Vaginal Health Index also improved; no adverse effects were seen.
Row on the Anise (Aniseed) page · PubMed 42152642 (opens PubMed)